A research carried out in Nigeria by scientists from the University of Edinburgh, England, revealed that one in every four Nigerian is at risk of being diagnosed with high blood pressure.

High blood pressure - also known as hypertension - which can cause stroke, heart disease and kidney disease, is twice as high in Nigeria compared with other East African countries and very few are aware that they have the condition.

The study also revealed that the figure will sharply rise as more Nigerians continue to live like westerners lives until drastic measures are put in place.

There were more than 20 million cases of hypertension in Nigeria in 2010, affecting one-in-three men and one-in-four women and researchers predict a rise in figure to 39 million cases by 2030.

Their findings have been published in the “Journal of Hypertension” and it is the first up-to-date nationwide estimate showing how hypertension affects Nigerians at an alarming rate.
with all the cases of insecurity ,unemployment and all we just pray nigerians learn to be preactive and not reactive . eat well ,rest well and trust God

Hypertension is a complex multifactorial disorder with genetic, environmental and demographic factors contributing to its prevalence. The genetic element contribution to blood pressure variation ranges from 30 to 50%. Therefore, identifying hypertension susceptibility genes will help understanding the pathophysiology of the disease. In addition to the potential impact of genomic information in selecting antihypertensive drug therapy, it may also help in recognizing those at risk of developing the disease, which may lead to new preventive approaches. Several strategies and methods have been used to identify hypertension susceptibility genes. Currently, genetic analysis of such data produced complex results, which makes it difficult to draw final conclusion on the use of genomic data in management of hypertension. This review attempts to summarize present known genetic variations that may be implicated in the pathogenesis of hypertension and to discuss various research strategies used to identify them. It also highlights some of the opportunities and challenges, which may be encountered in interpreting the value of these genetic variations to improve management of hypertension.